Advertisement

Stroke in Old Age

  • David AbernethyEmail author
Chapter
  • 1.3k Downloads

Abstract

  • Three quarters of all strokes occur over age 65, and these strokes in the older age group are much more often fatal.

  • Stroke is the fourth most important cause of death and the major cause of adult disability.

  • Both stroke prevention after TIA and minor stroke and the acute treatment of ischaemic stroke are highly effective at any age.

  • Atrial fibrillation is an important largely preventable cause of severe stroke in the elderly, and prophylactic effective anticoagulation should be much more widely used.

  • “Time is brain”—thrombolysis and clot retrieval for acute stroke must be treated urgently.

  • Successful stroke prevention and treatment require continuous improvement of stroke systems and repeated public awareness campaigns.

References

  1. 1.
    Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JNE, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA, Parag V, et al. 30-year trends in stroke rates and outcome in Auckland, New Zealand (1981–2012): a multi-ethnic population-based series of studies. PLoS One. 2015;10(8):e0134609.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–30.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJB, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–89.CrossRefPubMedGoogle Scholar
  6. 6.
    Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med. 1999;159(7):677–85.CrossRefPubMedGoogle Scholar
  7. 7.
    Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48(3):194–8.PubMedGoogle Scholar
  8. 8.
    Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978;28(8):754–62.CrossRefPubMedGoogle Scholar
  9. 9.
    Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke. 1989;20(3):333–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Dennis MS, Bamford JM, Sandercock PA, Warlow CP. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke. 1989;20(11):1494–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF. The capsular warning syndrome: pathogenesis and clinical features. Neurology. 1993;43(5):957–62.CrossRefPubMedGoogle Scholar
  12. 12.
    Kumar S, Goddeau RP Jr, Selim MH, Thomas A, Schlaug G, Alhazzani A, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology. 2010;74(11):893–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Akoudad S, Portegies MLP, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam study. Circulation. 2015;132(6):509–16.CrossRefPubMedGoogle Scholar
  14. 14.
    Nadarajan V, Perry RJ, Johnson J, Werring DJ. Transient ischaemic attacks: mimics and chameleons. Pract Neurol. 2014;14(1):23–31.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276–93.CrossRefPubMedGoogle Scholar
  16. 16.
    A classification and outline of cerebrovascular diseases. II. Stroke 1975;6(5):564–616.Google Scholar
  17. 17.
    Paul NLM, Simoni M, Rothwell PM, Study OV. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12(1):65–71.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Wardlaw JM, Brazzelli M, Chappell FM, Miranda H, Shuler K, Sandercock PAG, et al. ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology. 2015;85(4):373–80.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363(9425):1925–33.CrossRefPubMedGoogle Scholar
  20. 20.
    Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Wang Y, Pan Y, Zhao X, Li H, Wang D, Johnston SC, et al. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: one-year outcomes. Circulation. 2015;132(1):40–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM, North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170(7):1105–9.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Strömberg S, Gelin J, Osterberg T, Bergström GML, Karlström L, Osterberg K, et al. Very urgent carotid endarterectomy confers increased procedural risk. Stroke. 2012;43(5):1331–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. 2012;(9):CD000515.
  26. 26.
    Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.CrossRefPubMedGoogle Scholar
  28. 28.
    Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–86.CrossRefPubMedGoogle Scholar
  29. 29.
    Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25(4):382–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Bogousslavsky J, Van Melle G, Regli F, Kappenberger L. Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Stroke Registry. Neurology. 1990;40(7):1046–50.CrossRefPubMedGoogle Scholar
  31. 31.
    Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Schmahmann JD, Macmore J, Vangel M. Cerebellar stroke without motor deficit: clinical evidence for motor and non-motor domains within the human cerebellum. Neuroscience. 2009;162(3):852–61.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Caplan LR. “Top of the basilar” syndrome. Neurology. 1980;30(1):72–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Lee H, Sohn SI, Cho YW, Lee SR, Ahn BH, Park BR, et al. Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns. Neurology. 2006;67(7):1178–83.CrossRefPubMedGoogle Scholar
  35. 35.
    Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMedGoogle Scholar
  36. 36.
    Newman-Toker DE, Curthoys IS, Halmagyi GM. Diagnosing stroke in acute vertigo: the HINTS family of eye movement tests and the future of the “Eye ECG”. Semin Neurol. 2015;35(5):506–21.CrossRefPubMedGoogle Scholar
  37. 37.
    Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296(24):2939–46.CrossRefPubMedGoogle Scholar
  38. 38.
    Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42(6):1775–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38(3):948–54.CrossRefPubMedGoogle Scholar
  40. 40.
    Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.CrossRefPubMedGoogle Scholar
  41. 41.
    Kumar G, Shahripour RB, Alexandrov AV. Recanalization of acute basilar artery occlusion improves outcomes: a meta-analysis. J Neurointerv Surg. 2015;7(12):868–74.CrossRefPubMedGoogle Scholar
  42. 42.
    Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581–641.CrossRefPubMedGoogle Scholar
  44. 44.
    Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJB, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.CrossRefPubMedGoogle Scholar
  45. 45.
    de Los Ríos la Rosa F, Khoury J, Kissela BM, Flaherty ML, Alwell K, Moomaw CJ, et al. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke. 2012;43(6):1591–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Kim JT, Park MS, Chang J, Lee JS, Choi KH, Cho KH. Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke. PLoS One. 2013;8(8):e70996.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Ferrari J, Knoflach M, Kiechl S, Willeit J, Schnabl S, Seyfang L, et al. Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology. 2010;74(2):136–41.CrossRefPubMedGoogle Scholar
  48. 48.
    Rost NS, Masrur S, Pervez MA, Viswanathan A, Schwamm LH. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology. 2009;73(23):1957–62.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013;84(3):277–80.CrossRefPubMedGoogle Scholar
  50. 50.
    Investigators G. The effects of tissue plasminogen activator, streptokinase, or both on coronary- artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993;329(22):1615–22.CrossRefGoogle Scholar
  51. 51.
    Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59(5):669–74.CrossRefPubMedGoogle Scholar
  52. 52.
    Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36(8):1705–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab. 2007;27(9):1616–22.CrossRefPubMedGoogle Scholar
  54. 54.
    Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, Garcia Barragan N, Garcia Caldentey J, Hernandez-Medrano I, et al. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc Dis. 2012;34(2):115–20.CrossRefPubMedGoogle Scholar
  55. 55.
    Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S, et al. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke. 2009;40(4):1522–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013;44(4):1080–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology. 2003;60(9):1525–7.CrossRefPubMedGoogle Scholar
  58. 58.
    Hill MD, Buchan AM. Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172(10):1307–12.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Engelter ST, Fluri F, Buitrago-Téllez C, Marsch S, Steck AJ, Rüegg S, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol. 2005;252(10):1167–70.CrossRefPubMedGoogle Scholar
  60. 60.
    Al-Khudari S, Loochtan MJ, Peterson E, Yaremchuk KL. Management of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2011;121(11):2327–34.CrossRefPubMedGoogle Scholar
  61. 61.
    O’Carroll CB, Aguilar MI. Management of postthrombolysis hemorrhagic and orolingual angioedema complications. Neurohospitalist. 2015;5(3):133–41.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Yaghi S, Eisenberger A, Willey JZ. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol. 2014;71(9):1181–5.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Jalbert JJ, Nguyen LL, Gerhard-Herman MD, Jaff MR, White CJ, Rothman AT, et al. Outcomes after carotid artery stenting in Medicare beneficiaries, 2005 to 2009. JAMA Neurol. 2015;72(3):276–86.CrossRefPubMedGoogle Scholar
  64. 64.
    Frontera JA, Lewin Iii JJ, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage : a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6–46.CrossRefPubMedGoogle Scholar
  65. 65.
    Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for health- care professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Mann G, Hankey GJ, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke. 1999;30(4):744–8.CrossRefPubMedGoogle Scholar
  67. 67.
    Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365(9461):755–63.CrossRefPubMedGoogle Scholar
  68. 68.
    Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365(9461):764–72.CrossRefPubMedGoogle Scholar
  69. 69.
    Geeganage C, Beavan J, Ellender S, Bath PMW. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012;10:CD000323.PubMedGoogle Scholar
  70. 70.
    Geeganage CM, Sprigg N, Bath MW, Bath PMW. Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis. 2013;22(7):1018–27.CrossRefPubMedGoogle Scholar
  71. 71.
    Whiteley WN, Adams HP Jr, Bath PMW, Berge E, Sandset PM, Dennis M, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. 2013;12(6):539–45.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, et al. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382(9891):516–24.CrossRefGoogle Scholar

Copyright information

© The Editor(s)  2018

Authors and Affiliations

  1. 1.Department of MedicineUniversity of Otago, WellingtonWellingtonNew Zealand
  2. 2.Wellington Regional HospitalWakefield Specialist Medical CentreWellingtonNew Zealand

Personalised recommendations